Antiviral activities of ISG20 in positive-strand RNA virus infections

Virology

Volumn 409, Issue 2, 2011, Pages 175-188

  Zhou, Zhi ^a,e   Wang, Nan ^b   Woodson, Sara E ^a   Dong, Qingming ^b   Wang, Jie ^b   Liang, Yuqiong ^a   Rijnbrand, Rene ^a,f   Wei, Lai ^c   Nichols, Joan E ^a   Guo, Ju Tao ^d   Holbrook, Michael R ^a,g   Lemon, Stanley M ^a,h   Li, Kui ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c PEKING UNIVERSITY   (China)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e CHONGQING MEDICAL UNIVERSITY   (China)

^f VERTEX PHARMACEUTICALS   (United States)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^h UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Antiviral; Bovine viral diarrhea virus; Hepatitis A virus; Hepatitis C virus; Innate immunity; Interferon; ISG20; ISG20L1; ISG20L2; Severe acute respiratory syndrome coronavirus; Yellow fever virus

Indexed keywords

EXONUCLEASE; INTERFERON STIMULATED PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BOVINE DIARRHEA VIRUS; CELL CULTURE; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVITY; FLAVIVIRUS; GENE OVEREXPRESSION; HEPATITIS A VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INHIBITION KINETICS; NONHUMAN; PESTIVIRUS; PICORNAVIRUS; PRIORITY JOURNAL; RNA VIRUS; SARS CORONAVIRUS; VIRUS REPLICATION; YELLOW FEVER FLAVIVIRUS;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; EXODEOXYRIBONUCLEASES; EXONUCLEASES; HUMANS; MOLECULAR SEQUENCE DATA; PLAQUE ASSAY; RNA VIRUSES; RNA, VIRAL; SEQUENCE ALIGNMENT; VIRAL LOAD; VIRUS REPLICATION;

ANIMALIA; BOVINE VIRAL DIARRHEA VIRUS 1; CORONAVIRUS; FLAVIVIRUS; HEPATITIS A VIRUS; HEPATITIS C VIRUS; PESTIVIRUS; PICORNAVIRIDAE; RNA VIRUSES; SARS CORONAVIRUS; YELLOW FEVER VIRUS;

EID: 78650295825     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.10.008     Document Type: Article

References (60)

1. Akagi T., Sasai K., Hanafusa H. Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(23):13567-13572.
2. Bigger C.B., Brasky K.M., Lanford R.E. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J. Virol. 2001, 75(15):7059-7066.
3. Blight K.J., McKeating J.A., Rice C.M. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 2002, 76(24):13001-13014.
4. Buckwold V.E., Beer B.E., Donis R.O. Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents. Antiviral Res. 2003, 60(1):1-15.
5. Chang K.S., Cai Z., Zhang C., Sen G.C., Williams B.R., Luo G. Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities. J. Virol. 2006, 80(15):7364-7374.
6. Chen Z., Rijnbrand R., Jangra R.K., Devaraj S.G., Qu L., Ma Y., Lemon S.M., Li K. Ubiquitination and proteasomal degradation of interferon regulatory factor-3 induced by Npro from a cytopathic bovine viral diarrhea virus. Virology 2007, 366(2):277-292.
7. Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W. Treatment of SARS with human interferons. Lancet 2003, 362(9380):293-294.
8. Coute Y., Kindbeiter K., Belin S., Dieckmann R., Duret L., Bezin L., Sanchez J.C., Diaz J.J. ISG20L2, a novel vertebrate nucleolar exoribonuclease involved in ribosome biogenesis. Mol. Cell. Proteomics 2008, 7(3):546-559.
9. de Lang A., Baas T., Teal T., Leijten L.M., Rain B., Osterhaus A.D., Haagmans B.L., Katze M.G. Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques. PLoS Pathog. 2007, 3(8):e112.
10. Degols G., Eldin P., Mechti N. ISG20, an actor of the innate immune response. Biochimie 2007, 89(6-7):831-835.
11. Devaraj S.G., Wang N., Chen Z., Tseng M., Barretto N., Lin R., Peters C.J., Tseng C.T., Baker S.C., Li K. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem. 2007, 282(44):32208-32221.
12. Espert L., Degols G., Gongora C., Blondel D., Williams B.R., Silverman R.H., Mechti N. ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J. Biol. Chem. 2003, 278(18):16151-16158.
13. Espert L., Degols G., Lin Y.L., Vincent T., Benkirane M., Mechti N. Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1. J. Gen. Virol. 2005, 86(Pt 8):2221-2229.
14. Espert L., Eldin P., Gongora C., Bayard B., Harper F., Chelbi-Alix M.K., Bertrand E., Degols G., Mechti N. The exonuclease ISG20 mainly localizes in the nucleolus and the Cajal (Coiled) bodies and is associated with nuclear SMN protein-containing complexes. J. Cell. Biochem. 2006, 98(5):1320-1333.
15. Flodstrom-Tullberg M., Hultcrantz M., Stotland A., Maday A., Tsai D., Fine C., Williams B., Silverman R., Sarvetnick N. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J. Immunol. 2005, 174(3):1171-1177.
16. Guix S., Asanaka M., Katayama K., Crawford S.E., Neill F.H., Atmar R.L., Estes M.K. Norwalk virus RNA is infectious in mammalian cells. J. Virol. 2007, 81(22):12238-12248.
17. Haagmans B.L., Kuiken T., Martina B.E., Fouchier R.A., Rimmelzwaan G.F., van Amerongen G., van Riel D., de Jong T., Itamura S., Chan K.H., Tashiro M., Osterhaus A.D. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med. 2004, 10(3):290-293.
18. Hao Y., Yang D. Cloning, eukaryotic expression of human ISG20 and preliminary study on the effect of its anti-HBV. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2008, 28(1):11-13.
19. Hattermann K., Muller M.A., Nitsche A., Wendt S., Donoso Mantke O., Niedrig M. Susceptibility of different eukaryotic cell lines to SARS-coronavirus. Arch. Virol. 2005, 150(5):1023-1031.
20. Ikeda M., Yi M., Li K., Lemon S.M. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J. Virol. 2002, 76(6):2997-3006.
21. Jangra, R.K., Yi, M., Lemon, S.M., 2010. DDX6 (Rck/p54) is required for efficient hepatitis C virus replication but not IRES-directed translation. J. Virol. 84 (13), 6810-6824.
22. Jiang D., Guo H., Xu C., Chang J., Gu B., Wang L., Block T.M., Guo J.T. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J. Virol. 2008, 82(4):1665-1678.
23. Jiang D., Weidner J.M., Qing M., Pan X.B., Guo H., Xu C., Zhang X., Birk A., Chang J., Shi P.Y., Block T.M., Guo J.T. Identification of five interferon-induced cellular proteins that inhibit west Nile virus and dengue virus infection. J. Virol. 2010, 84(16):8332-8341.
24. Kato T., Date T., Miyamoto M., Furusaka A., Tokushige K., Mizokami M., Wakita T. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 2003, 125(6):1808-1817.
25. Keskinen P., Nyqvist M., Sareneva T., Pirhonen J., Melen K., Julkunen I. Impaired antiviral response in human hepatoma cells. Virology 1999, 263(2):364-375.
26. Lanford R.E., Guerra B., Lee H., Averett D.R., Pfeiffer B., Chavez D., Notvall L., Bigger C. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons. J. Virol. 2003, 77(2):1092-1104.
27. Lanford R.E., Guerra B., Lee H., Chavez D., Brasky K.M., Bigger C.B. Genomic response to interferon-alpha in chimpanzees: implications of rapid downregulation for hepatitis C kinetics. Hepatology 2006, 43(5):961-972.
28. Lee J.H., Koh Y.A., Cho C.K., Lee S.J., Lee Y.S., Bae S. Identification of a novel ionizing radiation-induced nuclease, AEN, and its functional characterization in apoptosis. Biochem. Biophys. Res. Commun. 2005, 337(1):39-47.
29. Lemon S.M., Murphy P.C., Shields P.A., Ping L.H., Feinstone S.M., Cromeans T., Jansen R.W. Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination. J. Virol. 1991, 65:2056-2065.
30. Lerat H., Shimizu Y.K., Lemon S.M. Cell type-specific enhancement of hepatitis C virus internal ribosome entry site-directed translation due to 5″ nontranslated region substitutions selected during passage of virus in lymphoblastoid cells. J. Virol. 2000, 74(15):7024-7031.
31. Li K., Chen Z., Kato N., Gale M., Lemon S.M. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J. Biol. Chem. 2005, 280(17):16739-16747.
32. Li K., Foy E., Ferreon J.C., Nakamura M., Ferreon A.C., Ikeda M., Ray S.C., Gale M., Lemon S.M. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(8):2992-2997.
33. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999, 285(5424):110-113.
34. MacDonald M.R., Machlin E.S., Albin O.R., Levy D.E. The zinc finger antiviral protein acts synergistically with an interferon-induced factor for maximal activity against alphaviruses. J. Virol. 2007, 81(24):13509-13518.
35. Martin A., Lemon S.M. Hepatitis A virus: from discovery to vaccines. Hepatology 2006, 43(2 Suppl 1):S164-S172.
36. Muller S., Geffers R., Gunther S. Analysis of gene expression in Lassa virus-infected HuH-7 cells. J. Gen. Virol. 2007, 88(Pt 5):1568-1575.
37. Nguyen L.H., Espert L., Mechti N., Wilson D.M. The human interferon- and estrogen-regulated ISG20/HEM45 gene product degrades single-stranded RNA and DNA in vitro. Biochemistry 2001, 40(24):7174-7179.
38. Peiris J.S., Yuen K.Y., Osterhaus A.D., Stohr K. The severe acute respiratory syndrome. N. Engl. J. Med. 2003, 349(25):2431-2441.
39. Peiris J.S., Guan Y., Yuen K.Y. Severe acute respiratory syndrome. Nat. Med. 2004, 10(12 Suppl):S88-S97.
40. Rice C.M., Grakoui A., Galler R., Chambers T.J. Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol. 1989, 1(3):285-296.
41. Saito T., Owen D.M., Jiang F., Marcotrigiano J., Gale M. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 2008, 454(7203):523-527.
42. Samuel M.A., Whitby K., Keller B.C., Marri A., Barchet W., Williams B.R., Silverman R.H., Gale M., Diamond M.S. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 2006, 80(14):7009-7019.
43. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 2001, 55:255-281.
44. Silverman R.H. Viral encounters with 2″, 5″-oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol. 2007, 81(23):12720-12729.
45. Spiegel M., Pichlmair A., Muhlberger E., Haller O., Weber F. The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein. J. Clin. Virol. 2004, 30(3):211-213.
46. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 1998, 67:227-264.
47. Sumpter R., Loo Y.M., Foy E., Li K., Yoneyama M., Fujita T., Lemon S.M., Gale M. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 2005, 79(5):2689-2699.
48. Tang B.S., Chan K.H., Cheng V.C., Woo P.C., Lau S.K., Lam C.C., Chan T.L., Wu A.K., Hung I.F., Leung S.Y., Yuen K.Y. Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E. J. Virol. 2005, 79(10):6180-6193.
49. Tscherne D.M., Jones C.T., Evans M.J., Lindenbach B.D., McKeating J.A., Rice C.M. Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J. Virol. 2006, 80(4):1734-1741.
50. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 2005, 11(7):791-796.
51. Wang N., Liang Y., Devaraj S., Wang J., Lemon S.M., Li K. Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells. J. Virol. 2009, 83(19):9824-9834.
52. Wieland S., Thimme R., Purcell R.H., Chisari F.V. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(17):6669-6674.
53. Yi M., Lemon S.M. Replication of subgenomic hepatitis A virus RNAs expressing firefly luciferase is enhanced by mutations associated with adaptation of virus to growth in cultured cells. J. Virol. 2002, 76(3):1171-1180.
54. Yi M., Villanueva R.A., Thomas D.L., Wakita T., Lemon S.M. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(7):2310-2315.
55. Yoneyama M., Fujita T. Recognition of viral nucleic acids in innate immunity. Rev. Med. Virol. 2010, 20(1):4-22.
56. Zhang Y., Burke C.W., Ryman K.D., Klimstra W.B. Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J. Virol. 2007, 81(20):11246-11255.
57. Zheng X., Silverman R.H., Zhou A., Goto T., Kwon B.S., Kaufman H.E., Hill J.M. Increased severity of HSV-1 keratitis and mortality in mice lacking the 2-5A-dependent RNase L gene. Invest. Ophthalmol. Vis. Sci. 2001, 42(1):120-126.
58. Zheng B., He M.L., Wong K.L., Lum C.T., Poon L.L., Peng Y., Guan Y., Lin M.C., Kung H.F. Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma). J. Interferon Cytokine Res. 2004, 24(7):388-390.
59. Zhou A., Paranjape J., Brown T.L., Nie H., Naik S., Dong B., Chang A., Trapp B., Fairchild R., Colmenares C., Silverman R.H. Interferon action and apoptosis are defective in mice devoid of 2″, 5″-oligoadenylate-dependent RNase L. EMBO J. 1997, 16(21):6355-6363.
60. Zhou A., Paranjape J.M., Der S.D., Williams B.R., Silverman R.H. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 1999, 258(2):435-440.